Agiomix, a regional accredited lab for molecular and genetic testing, is proud to announce that, further to its accreditation in next generation sequencing, it has fulfilled the CAP proficiency testing requirements for molecular diagnostics. In addition, its result for hepatitis C virus (HCV) was 100% compliant with CAP proficiency testing.
Dr. Salah Al Janabi, Managing Director at Agiomix, commented “Agiomix is committed to providing its customers with the most accurate results for their testing. We are continuously participating in CAP proficiency testing to ensure that results provided to our customers are 100% accurate.”
About Agiomix FZ-LLC
Agiomix FZ-LLC is a genomics and molecular services lab, headquartered in Dubai, UAE with services throughout emerging markets. Agiomix offers Next Generation Sequencing, Microarray, PCR based assays in addition to specialized genetic and pathology tests to healthcare providers.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
